We would like to thank Dr Sunil Verma for the live tweets from the SABCS conference, and the newest breast cancer slide updates. Share your comments in the comment section!

 

Tweets from SABCS 2011:

December 8

bolero 2 results being presented by dr hortobagyi
Bolero 2 design-metastatic breast cancer :exemesrane alone or exemesrane and everolimus #sabcs
Striking benefit seen with updated analysis ..50% improvement in progression free survival #sabcs
A new milestone in breast cancer research and for our patients! #sabcs

Cleopatra trial presented by Jose Baselga # sabcs #breast cancer
The addition of pertuzumab to docetaxel and herceptin leads to a substantial improvement in PFS # sabcs #BreastCancer
Overall survival data is still premature from this study#sabcs #BreastCancer

December 7

Updates from SABCS San Antonio meeting
Now on stage Sandy Patterson B34 adjuvant clodronate in breast cancer
Clear benefit in pts over age of 50
Similar results seen in other bisphosphonate trial
Are we ready to change the paradigm of tx in ESBC
we need to reevaluate BPs specifically in post men pts
none of the presenters gave us a rationale on why BPs would work in the low estrogenic state